General Announcement::ASX:TLX; Nasdaq: TLX - Chinese NMPA Accepts New Drug Application for Illuccix

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Jan-2026 05:54:42
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq: TLX - Chinese NMPA Accepts New Drug Application for Illuccix
Announcement Reference
SG260120OTHRNGV4
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
20/01/2026 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq: TLX - Chinese NMPA Accepts New Drug Application for Illuccix

Attachments

20260120 Illuccix China NDA vFINAL.pdf
Total size =213K